Patents by Inventor Josef Eberl

Josef Eberl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6277561
    Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immuno-deficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.
    Type: Grant
    Filed: July 2, 1998
    Date of Patent: August 21, 2001
    Assignee: Dade Behring Marburg GmbH
    Inventors: Lutz G. Guertler, Josef Eberle, Albrecht v. Brunn, Stefan Knapp, Hans-Peter Hauser
  • Patent number: 6162631
    Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: December 19, 2000
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Hans-Peter Hauser, Stefan Knapp, Stefan Brust, Lutz G. Gurtler, Josef Eberle, Lazare Kaptue, Leopold Achengui Zekeng
  • Patent number: 5840480
    Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 (SEQ ID NO:56) and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immuno-deficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 24, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Lutz G. Guertler, Josef Eberle, Albrecht v. Brunn, Stefan Knapp, Hans-Peter Hauser
  • Patent number: 5798205
    Abstract: A novel HIV type O immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.
    Type: Grant
    Filed: February 16, 1996
    Date of Patent: August 25, 1998
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Hans-Peter Hauser, Stefan Knapp, Stefan Brust, Lutz G. Gurtler, Josef Eberle, Lazare Kaptue, Leopold Achenqui Zekeng
  • Patent number: 5770427
    Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 (SEQ ID NO:56) and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 23, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Lutz G. Guertler, Josef Eberle, Albrecht V. Brunn, Stefan Knapp, Hans-Peter Hauser
  • Patent number: 5759770
    Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 (SEQ ID NO:56) and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 2, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Lutz G. Guertler, Josef Eberle, Albrecht V. Brunn, Stefan Knapp, Hans-Peter Hauser
  • Patent number: 5635350
    Abstract: Method of determining polymerase activity by incubating the polymerase with a template nucleic acid, one detectable mononucleoside triphosphate and one immobilizable nucleoside triphosphate, binding the immobilizable nucleotides to a solid phase and detecting the bound delectable nucleotides and tests based thereon.
    Type: Grant
    Filed: February 3, 1995
    Date of Patent: June 3, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Josef Eberle, Rudolf Seibl, Christoph Kessler, Bernhard Konig
  • Patent number: 5413906
    Abstract: Method of determining polymerase activity by incubating the polymerase with a template nucleic acid, one detectable mononucleoside triphosphate and one immobilizable nucleoside triphosphate, binding the immobilizable nucleotides to a solid phase and detecting the bound detectable nucleotides and tests based thereon.
    Type: Grant
    Filed: March 19, 1993
    Date of Patent: May 9, 1995
    Assignee: Boehringer Mannheim GmbH
    Inventors: Josef Eberle, Rudolf Seibl, Christoph Kessler, Bernhard Konig